Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 18 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Related structures:
AlphaFold database: Q4QBD7
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 5 |
GO:0016491 | oxidoreductase activity | 2 | 5 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 35 | 39 | PF00656 | 0.434 |
CLV_NRD_NRD_1 | 2 | 4 | PF00675 | 0.534 |
CLV_NRD_NRD_1 | 51 | 53 | PF00675 | 0.440 |
CLV_NRD_NRD_1 | 86 | 88 | PF00675 | 0.423 |
CLV_PCSK_KEX2_1 | 2 | 4 | PF00082 | 0.534 |
CLV_PCSK_KEX2_1 | 51 | 53 | PF00082 | 0.488 |
CLV_PCSK_KEX2_1 | 86 | 88 | PF00082 | 0.419 |
CLV_PCSK_PC7_1 | 47 | 53 | PF00082 | 0.376 |
CLV_PCSK_SKI1_1 | 100 | 104 | PF00082 | 0.355 |
CLV_PCSK_SKI1_1 | 2 | 6 | PF00082 | 0.642 |
CLV_PCSK_SKI1_1 | 79 | 83 | PF00082 | 0.414 |
CLV_PCSK_SKI1_1 | 87 | 91 | PF00082 | 0.372 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.611 |
DOC_CKS1_1 | 80 | 85 | PF01111 | 0.337 |
DOC_CYCLIN_RxL_1 | 18 | 28 | PF00134 | 0.490 |
DOC_CYCLIN_yCln2_LP_2 | 23 | 29 | PF00134 | 0.493 |
DOC_PP1_RVXF_1 | 19 | 26 | PF00149 | 0.516 |
DOC_PP1_RVXF_1 | 60 | 67 | PF00149 | 0.419 |
DOC_PP1_RVXF_1 | 85 | 92 | PF00149 | 0.405 |
DOC_WW_Pin1_4 | 25 | 30 | PF00397 | 0.555 |
DOC_WW_Pin1_4 | 79 | 84 | PF00397 | 0.413 |
LIG_14-3-3_CanoR_1 | 100 | 105 | PF00244 | 0.400 |
LIG_14-3-3_CanoR_1 | 2 | 11 | PF00244 | 0.635 |
LIG_deltaCOP1_diTrp_1 | 88 | 98 | PF00928 | 0.508 |
LIG_FHA_1 | 101 | 107 | PF00498 | 0.371 |
LIG_FHA_1 | 18 | 24 | PF00498 | 0.622 |
LIG_FHA_1 | 3 | 9 | PF00498 | 0.617 |
LIG_FHA_2 | 80 | 86 | PF00498 | 0.403 |
LIG_HCF-1_HBM_1 | 111 | 114 | PF13415 | 0.400 |
LIG_LIR_Gen_1 | 63 | 73 | PF02991 | 0.402 |
LIG_LIR_Nem_3 | 63 | 69 | PF02991 | 0.390 |
LIG_LIR_Nem_3 | 97 | 102 | PF02991 | 0.348 |
LIG_REV1ctd_RIR_1 | 96 | 104 | PF16727 | 0.371 |
LIG_SH2_PTP2 | 101 | 104 | PF00017 | 0.351 |
LIG_SH2_SRC | 36 | 39 | PF00017 | 0.457 |
LIG_SH2_STAT5 | 101 | 104 | PF00017 | 0.460 |
LIG_SH2_STAT5 | 36 | 39 | PF00017 | 0.421 |
LIG_SH3_3 | 23 | 29 | PF00018 | 0.538 |
LIG_SUMO_SIM_par_1 | 30 | 35 | PF11976 | 0.452 |
LIG_TRAF2_1 | 82 | 85 | PF00917 | 0.486 |
MOD_CDK_SPxxK_3 | 79 | 86 | PF00069 | 0.407 |
MOD_CK2_1 | 79 | 85 | PF00069 | 0.396 |
MOD_GSK3_1 | 100 | 107 | PF00069 | 0.382 |
MOD_NEK2_1 | 104 | 109 | PF00069 | 0.369 |
MOD_PKA_1 | 2 | 8 | PF00069 | 0.620 |
MOD_PKA_2 | 2 | 8 | PF00069 | 0.633 |
MOD_ProDKin_1 | 25 | 31 | PF00069 | 0.553 |
MOD_ProDKin_1 | 79 | 85 | PF00069 | 0.414 |
TRG_ENDOCYTIC_2 | 101 | 104 | PF00928 | 0.411 |
TRG_ER_diArg_1 | 1 | 3 | PF00400 | 0.542 |
TRG_ER_diArg_1 | 51 | 53 | PF00400 | 0.488 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IKB5 | Leptomonas seymouri | 86% | 99% |
A0A0S4JCT0 | Bodo saltans | 71% | 100% |
A0A1X0NX91 | Trypanosomatidae | 74% | 100% |
A0A3S7WXI5 | Leishmania donovani | 98% | 100% |
A4HCQ2 | Leishmania braziliensis | 86% | 99% |
A4I077 | Leishmania infantum | 98% | 100% |
D0A9J4 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 72% | 100% |
D0A9J6 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 73% | 100% |
E9AW41 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 92% | 100% |